These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 37671212

  • 1. Crohn's Disease is a Greater Risk Factor for Nonalcoholic Fatty Liver Disease Compared to Ulcerative Colitis: A Systematic Review.
    Kodali A, Okoye C, Klein D, Mohamoud I, Olanisa OO, Parab P, Chaudhary P, Mukhtar S, Moradi A, Hamid P.
    Cureus; 2023 Aug; 15(8):e42995. PubMed ID: 37671212
    [Abstract] [Full Text] [Related]

  • 2. High incidence of non-alcoholic fatty liver disease in patients with Crohn's disease but not ulcerative colitis.
    Li D, Lu C, Yu C.
    Int J Clin Exp Pathol; 2017 Aug; 10(10):10633-10639. PubMed ID: 31966406
    [Abstract] [Full Text] [Related]

  • 3. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
    Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, Sung JJY, Kaplan GG.
    Lancet; 2017 Dec 23; 390(10114):2769-2778. PubMed ID: 29050646
    [Abstract] [Full Text] [Related]

  • 4. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study.
    Abenavoli L, Spagnuolo R, Scarlata GGM, Scarpellini E, Boccuto L, Luzza F.
    Medicina (Kaunas); 2023 Nov 01; 59(11):. PubMed ID: 38003983
    [Abstract] [Full Text] [Related]

  • 5. The MYTHS of De novo Crohn's Disease After Restorative Proctocolectomy with Ileal Pouch-anal Anastomosis for Ulcerative Colitis.
    James SD, Hawkins AT, Um JW, Ballard BR, Smoot DT, M'Koma AE.
    Jpn J Gastroenterol Hepatol; 2020 Nov 01; 3(2):. PubMed ID: 37584007
    [Abstract] [Full Text] [Related]

  • 6. Onset of Ulcerative Colitis in a Patient with Nonalcoholic Fatty Liver Disease (NAFLD): Dramatic Effect of Plant-based Diet for NAFLD.
    Chiba M, Nakane K, Abe H, Komatsu M, Tozawa H.
    Inflamm Bowel Dis; 2019 Oct 18; 25(11):e146-e147. PubMed ID: 31560040
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis.
    Hoffmann P, Jung V, Behnisch R, Gauss A.
    World J Gastroenterol; 2020 Dec 14; 26(46):7367-7381. PubMed ID: 33362390
    [Abstract] [Full Text] [Related]

  • 8. Differences in the prevalence of uveitis between Crohn's disease and ulcerative colitis: A systematic review and meta-analysis.
    Lin H, Zhang J, Liang C, Wu D, Tan Y, Luo L, Liu Z.
    Acta Ophthalmol; 2024 Jun 14; 102(4):e485-e492. PubMed ID: 37830172
    [Abstract] [Full Text] [Related]

  • 9. Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease.
    Zou ZY, Shen B, Fan JG.
    Inflamm Bowel Dis; 2019 Oct 18; 25(11):1764-1772. PubMed ID: 30918952
    [Abstract] [Full Text] [Related]

  • 10. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C, Loy L, Lönnfors S, Avedano L, Piovani D.
    World J Gastroenterol; 2020 Aug 07; 26(29):4343-4355. PubMed ID: 32848338
    [Abstract] [Full Text] [Related]

  • 11. Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Carr RM, Patel A, Bownik H, Oranu A, Kerner C, Praestgaard A, Forde KA, Reddy KR, Lichtenstein GR.
    Dig Dis Sci; 2017 May 07; 62(5):1354-1361. PubMed ID: 28265826
    [Abstract] [Full Text] [Related]

  • 12. Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-analysis.
    Trivedi HD, Lopes EW, Glissen Brown J, Dudani S, Lai M, Feuerstein JD, Pierce TT.
    J Clin Gastroenterol; 2023 Jul 01; 57(6):610-616. PubMed ID: 35648974
    [Abstract] [Full Text] [Related]

  • 13. The Impact of NAFLD on Hospitalization Outcomes in Patients With Inflammatory Bowel Diseases: Nationwide Analysis.
    Noorian S, Jeon Y, Nguyen MT, Sauk J, Limketkai BN.
    Inflamm Bowel Dis; 2022 Jun 03; 28(6):878-887. PubMed ID: 34374782
    [Abstract] [Full Text] [Related]

  • 14. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.
    Ananthakrishnan AN, Long MD, Martin CF, Sandler RS, Kappelman MD.
    Clin Gastroenterol Hepatol; 2013 Aug 03; 11(8):965-71. PubMed ID: 23376797
    [Abstract] [Full Text] [Related]

  • 15. Crohn's Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Aggarwal M, Garg R, Parthasarthy G, Nowacki AS, Padival R, McCullough A, Qazi T, Click B, Rieder F, Cohen BL.
    Dig Dis Sci; 2023 Mar 03; 68(3):1006-1015. PubMed ID: 35731428
    [Abstract] [Full Text] [Related]

  • 16. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history.
    Magrì S, Paduano D, Chicco F, Cingolani A, Farris C, Delogu G, Tumbarello F, Lai M, Melis A, Casula L, Fantini MC, Usai P.
    World J Gastroenterol; 2019 Oct 07; 25(37):5676-5686. PubMed ID: 31602167
    [Abstract] [Full Text] [Related]

  • 17. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
    Sourianarayanane A, Garg G, Smith TH, Butt MI, McCullough AJ, Shen B.
    J Crohns Colitis; 2013 Sep 07; 7(8):e279-85. PubMed ID: 23158500
    [Abstract] [Full Text] [Related]

  • 18. Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review.
    Martínez-Domínguez SJ, García-Mateo S, Laredo V, Gargallo-Puyuelo CJ, Gallego Llera B, López de la Cruz J, Gomollón F.
    Cancers (Basel); 2023 Jun 27; 15(13):. PubMed ID: 37444477
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of plasma Short chain fatty acid levels as markers for Inflammatory bowel disease.
    Kiasat A, Rautiainen S, Prast-Nielsen S, Engstrand L, Schuppe-Koistinen I, Gustafsson UO, Löf Granström A.
    Scand J Gastroenterol; 2023 Jun 27; 58(11):1246-1252. PubMed ID: 37272725
    [Abstract] [Full Text] [Related]

  • 20. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec 27; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.